Vulval disease in the postmenopausal patient: a guide to current management.
In spite of overwhelming evidence that vulvovaginal symptoms plague up to 46% of menopausal and perimenopausal women, and that there persists a reluctance to seek help among patients, adequate vulval and sexual histories are still woefully rare in general gynaecology clinics. This review aims to present the key points of an effective vulval history and an overview of the accepted current management of vulval disease postmenopause, in order that our patients feel encouraged to present with their problems.
Kingston
Abigail
A
Consultant in Obstetrics and Gynaecology, Salisbury NHS Foundation Trust, Salisbury, UK. Abigail.kingston@salisbury.nhs.uk
D000287:Administration, Topical; D003877:Dermatitis, Contact / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008010:Lichen Planus / Q000175:diagnosis / Q000188:drug therapy; D018459:Lichen Sclerosus et Atrophicus / Q000175:diagnosis / Q000188:drug therapy; D009450:Neurodermatitis / Q000175:diagnosis / Q000188:drug therapy; D017698:Postmenopause; D017410:Practice Guidelines as Topic; D012725:Sexual Behavior; D014845:Vulvar Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D014848:Vulvovaginitis / Q000175:diagnosis / Q000188:drug therapy